https://www.technologynetworks.com/genomics/news/tekmira-pharmaceuticals-tkmebola-clinical-trial-approved-211313
Investigational New Drug (IND) application for TKM-Ebola has been approved by the United States FDA, allowing Tekmira to initiate a Phase 1 clinical trial.
tekmira pharmaceuticalstkm ebolaclinical trialapprovedtechnology